Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gynecology

  Free Subscription


01.03.2021

4 Acta Obstet Gynecol Scand
5 Am J Obstet Gynecol
1 Aust N Z J Obstet Gynaecol
2 BMC Cancer
2 BMJ
1 Br J Cancer
2 Cancer
1 Cancer Lett
3 Eur J Obstet Gynecol Reprod Biol
6 Fertil Steril
10 Gynecol Oncol
2 Hum Reprod
2 Int J Cancer
6 Int J Gynaecol Obstet
4 J Clin Endocrinol Metab
1 J Clin Oncol
4 JAMA
1 Nat Rev Cancer
1 Obstet Gynecol
2 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Obstet Gynecol Scand

  1. DUMITRASCU-BIRIS D, Nzelu D, Dassios T, Nicolaides K, et al
    Chronic hypertension in pregnancy stratified by first trimester blood pressure control and adverse perinatal outcomes: a prospective observational study.
    Acta Obstet Gynecol Scand. 2021 Feb 20. doi: 10.1111/aogs.14132.
    PubMed         Abstract available

  2. D'SOUZA R, Horyn I, Jacob CE, Zaffar N, et al
    Birth outcomes in women with body mass index of 40 kg/m(2) or greater stratified by planned and actual mode of birth: a systematic review and meta-analysis.
    Acta Obstet Gynecol Scand. 2021;100:200-209.
    PubMed         Abstract available

  3. MAN Y, Bian Y, Zhao S, Zhao R, et al
    The effect of different endometrial preparations on women with polycystic ovary syndrome undergoing initial frozen embryo transfer: A historical cohort analysis.
    Acta Obstet Gynecol Scand. 2020 Dec 7. doi: 10.1111/aogs.14058.
    PubMed         Abstract available

  4. BUCKINGHAM P, Moulton JE, Subasinghe AK, Amos N, et al
    Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.
    Acta Obstet Gynecol Scand. 2021 Feb 20. doi: 10.1111/aogs.14129.
    PubMed         Abstract available


    Am J Obstet Gynecol

  5. GALHOTRA S, Mourad J
    Intraoperative View of Ovarian Vein Coils for Embolization.
    Am J Obstet Gynecol. 2021 Feb 22. pii: S0002-9378(21)00123.
    PubMed        

  6. MIODOWNIK S, Pikovsky O, Erez O, Kezerle Y, et al
    Unfolding the pathophysiology of congenital thrombotic thrombocytopenic purpura in pregnancy: Lessons from a cluster of familial cases.
    Am J Obstet Gynecol. 2021 Feb 20. pii: S0002-9378(21)00115.
    PubMed         Abstract available

  7. PAPAGEORGHIOU AT, Hulme R, Khalil A
    Cell-free DNA in twin pregnancy: time to change screening recommendations.
    Am J Obstet Gynecol. 2021 Feb 24. pii: S0002-9378(21)00121.
    PubMed        

  8. LUCHRISTT D, Brown O, Pidaparti M, Kenton K, et al
    Predicting obstetric anal sphincter injuries (OASIS) in patients who undergo vaginal birth after cesarean section (VBAC).
    Am J Obstet Gynecol. 2021 Feb 19. pii: S0002-9378(21)00103.
    PubMed         Abstract available

  9. ZHEN L, Li DZ
    Non-invasive prenatal testing for aneuploidy in twin pregnancies with maternal plasma DNA sequencing.
    Am J Obstet Gynecol. 2021 Feb 22. pii: S0002-9378(21)00120.
    PubMed        


    Aust N Z J Obstet Gynaecol

  10. BEST E, Lokuge B, Dunlop A, Dunford A, et al
    Unmet need for postpartum long-acting reversible contraception in women with substance use disorders and/or socioeconomic disadvantage.
    Aust N Z J Obstet Gynaecol. 2021 Feb 22. doi: 10.1111/ajo.13306.
    PubMed         Abstract available


    BMC Cancer

  11. WETTERGREN L, Ljungman L, Micaux Obol C, Eriksson LE, et al
    Sexual dysfunction and fertility-related distress in young adults with cancer over 5 years following diagnosis: study protocol of the Fex-Can Cohort study.
    BMC Cancer. 2020;20:722.
    PubMed         Abstract available

  12. KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
    Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
    BMC Cancer. 2020;20:577.
    PubMed         Abstract available


    BMJ

  13. TANNE JH
    US abortions: Nine in 10 laws on access since 2017 increased restrictions, study finds.
    BMJ. 2021;372:n542.
    PubMed        

  14. MN W, L J, Jw H, Ks R, et al
    Use of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation.
    BMJ. 2021;372:n214.
    PubMed         Abstract available


    Br J Cancer

  15. KYRGIOU M, Arbyn M, Bergeron C, Bosch FX, et al
    Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
    Br J Cancer. 2020;123:510-517.
    PubMed         Abstract available


    Cancer

  16. MUKAMA T, Kharazmi E, Sundquist K, Sundquist J, et al
    Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Cancer. 2021 Feb 23. doi: 10.1002/cncr.33456.
    PubMed         Abstract available

  17. MULLINS MA, Ruterbusch JJ, Clarke P, Uppal S, et al
    Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian cancer.
    Cancer. 2021 Feb 25. doi: 10.1002/cncr.33488.
    PubMed         Abstract available


    Cancer Lett

  18. KURNIT KC, Draisey A, Kazen RC, Chung C, et al
    Loss of CD73 shifts transforming growth factor-beta1 (TGF-beta1) from tumor suppressor to promoter in endometrial cancer.
    Cancer Lett. 2021 Feb 17. pii: S0304-3835(21)00062.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  19. FATEMI N, Ray PF, Ramezanali F, Shahani T, et al
    KH domain containing 3 like (KHDC3L) frame-shift mutation causes both recurrent pregnancy loss and hydatidiform mole.
    Eur J Obstet Gynecol Reprod Biol. 2021;259:100-104.
    PubMed         Abstract available

  20. ALONSO-NARANJO L, Gonzalez-Cantero A
    Pustular psoriasis of pregnancy managed with labor induction.
    Eur J Obstet Gynecol Reprod Biol. 2021 Feb 10. pii: S0301-2115(21)00057.
    PubMed        

  21. DVASH S, Cuckle H, Smorgick N, Vaknin Z, et al
    Increase rate of ruptured tubal ectopic pregnancy during the COVID-19 pandemic.
    Eur J Obstet Gynecol Reprod Biol. 2021;259:95-99.
    PubMed         Abstract available


    Fertil Steril

  22. ALECSANDRU D, Klimczak AM, Garcia Velasco JA, Pirtea P, et al
    Immunologic causes and thrombophilia in recurrent pregnancy loss.
    Fertil Steril. 2021 Feb 17. pii: S0015-0282(21)00038.
    PubMed         Abstract available

  23. MUTHIGI A, Jahandideh S, Bishop LA, Naeemi FK, et al
    Clarifying the relationship between total motile sperm counts and intrauterine insemination pregnancy rates.
    Fertil Steril. 2021 Feb 17. pii: S0015-0282(21)00035.
    PubMed         Abstract available

  24. ZHENG Y, Chen Y, Yi X
    Laparoscopic blockage of uterine artery in the management of large cornual pregnancy.
    Fertil Steril. 2021 Feb 18. pii: S0015-0282(20)32698.
    PubMed         Abstract available

  25. LEE M, Farrell RM, Flyckt R
    An insider perspective from Mayer-Rokitansky-Kuster-Hauser syndrome patients on uterus transplantation.
    Fertil Steril. 2021 Feb 20. pii: S0015-0282(21)00052.
    PubMed        

  26. VANDEN BRINK H, Pisch AJ, Lujan ME
    A comparison of two- and three-dimensional ultrasonographic methods for evaluation of ovarian follicle counts and classification of polycystic ovarian morphology.
    Fertil Steril. 2021 Feb 20. pii: S0015-0282(20)32207.
    PubMed         Abstract available

  27. BERNABEU R, Ortiz JA, Lledo B
    Exploring the epigenetic profile of women with poor ovarian reserve.
    Fertil Steril. 2021 Feb 23. pii: S0015-0282(20)32770.
    PubMed        


    Gynecol Oncol

  28. INCI MG, Anders L, Woopen H, Richter R, et al
    Frailty Index for prediction of surgical outcome in ovarian cancer: Results of a prospective study.
    Gynecol Oncol. 2021 Feb 16. pii: S0090-8258(21)00149.
    PubMed         Abstract available

  29. FRIEDLANDER M, Benson C, O'Connell RL, Reed N, et al
    Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903).
    Gynecol Oncol. 2021 Feb 16. pii: S0090-8258(21)00153.
    PubMed         Abstract available

  30. FABER MT, Sperling CD, Bennetsen AKK, Aalborg GL, et al
    A Danish nationwide study of risk factors associated with Type I and Type II endometrial cancer.
    Gynecol Oncol. 2021 Feb 16. pii: S0090-8258(21)00147.
    PubMed         Abstract available

  31. FELIX AS, Sherman ME
    Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship.
    Gynecol Oncol. 2021;160:643-645.
    PubMed        

  32. KURTZ JE, Gebski V, Sukhin V, Carey M, et al
    Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee.
    Gynecol Oncol. 2021 Feb 18. pii: S0090-8258(21)00155.
    PubMed         Abstract available

  33. SKORSTENGAARD M, Frederiksen ME, Baillet MV, Beau AB, et al
    Cervical cancer survivors and health care use: A Danish population-based register study.
    Gynecol Oncol. 2021 Feb 19. pii: S0090-8258(21)00139.
    PubMed         Abstract available

  34. DA CRUZ PAULA A, DeLair DF, Ferrando L, Fix DJ, et al
    Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.
    Gynecol Oncol. 2021 Feb 20. pii: S0090-8258(21)00152.
    PubMed         Abstract available

  35. AREND RC, Monk BJ, Herzog TJ, Moore KN, et al
    Utilizing an interim futility analysis of the OVAL study (VB-111-701/GOG 3018) for potential reduction of risk: A phase III, double blind, randomized controlled trial of ofranergene obadenovec (VB-111) and weekly paclitaxel in patients with platinum r
    Gynecol Oncol. 2021 Feb 23. pii: S0090-8258(21)00151.
    PubMed         Abstract available

  36. SJOQUIST KM, Espinoza D, Mileshkin L, Ananda S, et al
    REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer.
    Gynecol Oncol. 2021 Feb 23. pii: S0090-8258(21)00109.
    PubMed         Abstract available

  37. SCHRIER E, Xiong N, Thompson E, Poort H, et al
    Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors.
    Gynecol Oncol. 2021 Feb 23. pii: S0090-8258(21)00168.
    PubMed         Abstract available


    Hum Reprod

  38. VAN EEKELEN R, Wang R, Danhof NA, Mol F, et al
    Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
    Hum Reprod. 2021 Feb 22. pii: 6145936. doi: 10.1093.
    PubMed         Abstract available

  39. VAIARELLI A, Cimadomo D, Rienzi L, Ubaldi FM, et al
    Reply: 'Second stimulation in the same ovarian cycle', probably a terminology more appropriate than 'luteal phase stimulation' in the DuoStim protocol.
    Hum Reprod. 2021 Feb 22. pii: 6146063. doi: 10.1093.
    PubMed        


    Int J Cancer

  40. HALL MT, Smith MA, Simms KT, Barnabas R, et al
    Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33533.
    PubMed         Abstract available

  41. YANG J, Sasamoto N, Babic A, Vitonis AF, et al
    Intrauterine device use and risk of ovarian cancer: results from the New England Case-Control study and Nurses' Health Studies.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33531.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  42. ALI MK, Emam SM, Abdel-Aleem MA, Sobh AMA, et al
    Misoprostol versus expectant management in women with incomplete first-trimester miscarriage after failed primary misoprostol treatment: A randomized clinical trial.
    Int J Gynaecol Obstet. 2021 Feb 22. doi: 10.1002/ijgo.13652.
    PubMed         Abstract available

  43. VITALE SG, Lagana AS, Torok P, Lasmar RB, et al
    Virtual sonographic hysteroscopy in assisted reproduction: A retrospective cost-effectiveness analysis.
    Int J Gynaecol Obstet. 2021 Feb 22. doi: 10.1002/ijgo.13651.
    PubMed         Abstract available

  44. ABDALLAH W, Abi Tayeh G, Cortbaoui E, Nassar M, et al
    Cesarean section rates in a tertiary referral hospital in Beirut from 2018 to 2020: Our experience using the Robson Classification.
    Int J Gynaecol Obstet. 2021 Feb 22. doi: 10.1002/ijgo.13653.
    PubMed         Abstract available

  45. WONG CLH, So PL
    Prevalence and risk factors for malignancy in hysteroscopy resected endometrial polyps.
    Int J Gynaecol Obstet. 2021 Feb 23. doi: 10.1002/ijgo.13656.
    PubMed         Abstract available

  46. LI D, Zhang J, Kiryu S, Zhang X, et al
    Clinical and CT features of ovarian torsion in infants, children and adolescents.
    Int J Gynaecol Obstet. 2021 Feb 23. doi: 10.1002/ijgo.13657.
    PubMed         Abstract available

  47. ABEDZADEH-KALAHROUDI M, Sehat M, Vahedpour Z, Talebian P, et al
    Maternal and neonatal outcomes of pregnant patients with COVID-19: A prospective cohort study.
    Int J Gynaecol Obstet. 2021 Feb 26. doi: 10.1002/ijgo.13661.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  48. BROWNFOOT F
    Uncovering the molecular cause of preeclampsia - The role of glutathionylation of the Na+/K+ ATPase transporter.
    J Clin Endocrinol Metab. 2021 Feb 22. pii: 6146458. doi: 10.1210.
    PubMed        

  49. ZHAI J, Li S, Hu J, Gao M, et al
    In silico, in vitro and in vivo analysis identifies endometrial circadian clock genes in recurrent implantation failure.
    J Clin Endocrinol Metab. 2021 Feb 23. pii: 6146813. doi: 10.1210.
    PubMed         Abstract available

  50. XING C, Li C, He B
    Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
    J Clin Endocrinol Metab. 2020;105.
    PubMed         Abstract available

  51. HA J, Park SS, Park S, Yoon JH, et al
    Effects of Hormone Replacement Therapy on Bone Mass after Allogeneic Hematopoietic Stem Cell Transplantation.
    J Clin Endocrinol Metab. 2020 Jun 27. pii: 5864155. doi: 10.1210.
    PubMed         Abstract available


    J Clin Oncol

  52. MAKKER V, Taylor MH, Aghajanian C, Oaknin A, et al
    Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer.
    J Clin Oncol. 2020;38:2981-2992.
    PubMed         Abstract available


    JAMA

  53. GELDSETZER P, Lemp JM
    Cervical Cancer Screening in Low- and Middle-Income Countries-Reply.
    JAMA. 2021;325:790-791.
    PubMed        

  54. CREMER M, Alfaro K, Masch R
    Cervical Cancer Screening in Low- and Middle-Income Countries.
    JAMA. 2021;325:790.
    PubMed        

  55. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
    PubMed        

  56. YADAV K, Lewis RJ
    Immortal Time Bias in Observational Studies.
    JAMA. 2021;325:686-687.
    PubMed        


    Nat Rev Cancer

  57. HARJES U
    IgA strikes twice in ovarian cancer.
    Nat Rev Cancer. 2021 Feb 24. pii: 10.1038/s41568-021-00342.
    PubMed        


    Obstet Gynecol

  58. GOTLURU C, Roach A, Cherry SH, Runowicz CD, et al
    Sex, Hormones, Immune Functions, and Susceptibility to Coronavirus Disease 2019 (COVID-19)-Related Morbidity.
    Obstet Gynecol. 2021;137:423-429.
    PubMed         Abstract available


    Oncogene

  59. MORGAN EL, Patterson MR, Barba-Moreno D, Scarth JA, et al
    The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
    Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01679.
    PubMed         Abstract available

  60. XING Y, Chen L, Gu H, Yang C, et al
    Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
    Oncogene. 2021 Feb 22. pii: 10.1038/s41388-021-01693.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: